Ji-na Zheng

Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

MetS Risk Score: A Clear Scoring Model to Predict a 3-Year Risk for Metabolic Syndrome.

MetS Risk Score: A Clear Scoring Model to Predict a 3-Year Risk for Metabolic Syndrome.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: September 06, 2018

Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysis.

Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysis.

Journal: Expert review of gastroenterology & hepatology

Published: July 15, 2017

Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis.

Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis.

Journal: Expert review of anti-infective therapy

Published: March 21, 2017

NAFL screening score: A basic score identifying ultrasound-diagnosed non-alcoholic fatty liver.

NAFL screening score: A basic score identifying ultrasound-diagnosed non-alcoholic fatty liver.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: February 02, 2017

Serum alkaline phosphatase, a risk factor for non-alcoholic fatty liver, but only for women in their 30s and 40s: evidence from a large cohort study.

Serum alkaline phosphatase, a risk factor for non-alcoholic fatty liver, but only for women in their 30s and 40s: evidence from a large cohort study.

Journal: Expert review of gastroenterology & hepatology

Published: January 18, 2017

The NAFL Risk Score: A simple scoring model to predict 4-y risk for non-alcoholic fatty liver.

The NAFL Risk Score: A simple scoring model to predict 4-y risk for non-alcoholic fatty liver.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: October 25, 2016

Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection.

Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection.

Journal: Journal of clinical and translational hepatology

Published: September 04, 2016

Comparative efficacy of oral nucleotide analogues for the prophylaxis of hepatitis B virus recurrence after liver transplantation: a network meta-analysis.

Comparative efficacy of oral nucleotide analogues for the prophylaxis of hepatitis B virus recurrence after liver transplantation: a network meta-analysis.

Journal: Expert review of anti-infective therapy

Published: August 06, 2016

National incidence of autoimmune liver diseases and its relationship with the human development index.

National incidence of autoimmune liver diseases and its relationship with the human development index.

Journal: Oncotarget

Published: April 23, 2016

Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma.

Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma.

Journal: Scientific reports

Published: March 10, 2016

Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1.

Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1.

Journal: Medicine

Published: March 06, 2016

Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.

Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.

Journal: Oncotarget

Published: February 28, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026